Isorhamnetin ameliorates colitis-associated colorectal cancer progression by modulating S100A8/A9 and epithelial-mesenchymal transition
The publisher did not provide an abstract — full text is available via the link below.
The publisher did not provide an abstract — full text is available via the link below.